Abir Malik is a scientific program analyst in NCATS’ Office of Drug Development Partnership Programs, where she provides analytical and administrative support for the Illuminating the Druggable Genome (IDG) program sponsored by the NIH Common Fund. The IDG program intends to expand scientific knowledge and create information repositories for understudied proteins that potentially could affect health and disease. Some of Malik’s responsibilities involve releasing programmatic information to appropriate personnel, collaborating on reports, tracking and documenting milestone progress, and conducting grant-related analysis. Prior to joining NCATS in January 2021, she was a research associate working on assay development for high-throughput biodosimetry and research to isolate and characterize a single extracellular vesicle with multimarker surface signatures.
Malik holds a Master of Science in biotechnology from Georgetown University in Washington, D.C., with a concentration in various science courses, and a Bachelor of Science in sociology from Virginia Commonwealth University in Richmond, Virginia.
Prior to her industry experience, Malik’s research background included an internship at the Georgetown University Medical Center, where she tested prenatal stress on neuroblastoma phenotypes. She also completed an internship at the Lawrence Livermore National Laboratory, where she characterized phenotypes of brain cells in cell culture models. Malik’s research in industry mainly focused on extracellular vesicles.